(Total Views: 750)
Posted On: 08/24/2020 9:49:54 AM
Post# of 153974
Fair point but I don't think affects our S/C enrollment at least. It looks like CPT can be used by our trial participants:
From the s/c clinical trial page.
https://clinicaltrials.gov/ct2/show/NCT043472...amp;rank=6
Quote:
Subject who were prescribed (1) hydroxychloroquine or chloroquine with or without azithromycin, (2) Remdesivir, (3) convalescent plasma therapy, or (4) immunomodulatory treatments (including but not limited to sarilumab, clazakizumab, tocilizumab, and anakinra) for the off-label treatment of COVID-19 prior to study enrollment may be included and may continue to receive these agents as part of standard-of-care.
From the s/c clinical trial page.
https://clinicaltrials.gov/ct2/show/NCT043472...amp;rank=6
(0)
(0)
